http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101989019-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B33Y70-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B33Y80-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B33Y80-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B33Y70-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
filingDate 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101989019-B1
titleOfInvention A core-shell structured scaffold for hard tissue regeneration with two crystalline phase and preparing method thereof
abstract The present invention relates to a core-shell structure for hard tissue regeneration support having a heterogeneous crystal phase and a method for producing the same, wherein the core-shell structure for hard tissue regeneration support having a heterogeneous crystal phase according to the present invention comprises apatite- Not only has a mechanical property as a support but also has biodegradability, so that the function necessary for hard tissue regeneration is remarkably enhanced. It also has the advantage that it can be carried out at room temperature in the production process.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102444676-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220008953-A
priorityDate 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015125537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101627184-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452282177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21862903
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453658151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54726804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425964820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22340838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456

Total number of triples: 50.